Neurocrine Biosciences Inc (NASDAQ:NBIX)

103.05
Delayed Data
As of Oct 15
 -0.89 / -0.86%
Today’s Change
84.77
Today|||52-Week Range
120.27
+7.51%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close104.02
Today’s open104.88
Day’s range102.73 - 105.25
Volume491,976
Average volume (3 months)640,158
Market cap$9.9B
Data as of 3:59pm ET, 10/15/2021

Growth & Valuation

Earnings growth (last year)+983.16%
Earnings growth (this year)-45.99%
Earnings growth (next 5 years)+18.94%
Revenue growth (last year)+32.71%
P/E ratio27.7
Price/Sales8.96
Price/Book8.67

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...+1.85+1.41%
ZLABZai Lab Ltd+2.04+2.06%
XLRNAcceleron Pharma Inc+0.74+0.43%
CRSPCRISPR Therapeutics ...+4.05+4.21%
Data as of 5:45pm ET, 10/15/2021

Financials

Next reporting dateNovember 2, 2021
EPS forecast (this quarter)$0.61
Annual revenue (last year)$1.0B
Annual profit (last year)$407.3M
Net profit margin38.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts